This topic contains a solution. Click here to go to the answer

Author Question: If a patient is deemed a partial responder during the termination phases of interpersonal therapy, ... (Read 19 times)

Bob-Dole

  • Hero Member
  • *****
  • Posts: 547
If a patient is deemed a partial responder during the termination phases of interpersonal therapy, the therapist will:
 
  a. instill guilt to motivate the patient to be more compliant.
  b. review which skills taught were useful and encourage their use.
  c. encourage the patient to accept that their symptoms are chronic.
  d. terminate treatment regardless because IPT only allows for 16 sessions.

Question 2

Using Bartholomew's four category model of adult attachment, which of the following styles is most consistently correlated with depression?
 
  a. Secure anxiety
  b. Dismissing
  c. Preoccupied
  d. Fearful



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aburgess

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

B

Answer to Question 2

D




Bob-Dole

  • Member
  • Posts: 547
Reply 2 on: Jul 30, 2018
Thanks for the timely response, appreciate it


nyrave

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

For a complete list of videos, visit our video library